Skip to main content
Ruth Ann Vleugels, MD, Dermatology, Boston, MA

Ruth Ann Vleugels MD


Assistant Professor of Dermatology, Brigham and Women's Hospital

Join to View Full Profile
  • 221 Longwood AveBoston, MA 02115

  • Phone+1 617-732-4918

Dr. Vleugels is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • Mass General Brigham/Massachusetts General Hospital/Beth Israel Deaconess Medical Center/Brigham and Women's Hosp
    Mass General Brigham/Massachusetts General Hospital/Beth Israel Deaconess Medical Center/Brigham and Women's HospResidency, Dermatology, 2005 - 2008
  • Mass General Brigham/Brigham and Women's Hospital
    Mass General Brigham/Brigham and Women's HospitalInternship, Internal Medicine, 2004 - 2005
  • Vanderbilt University School of Medicine
    Vanderbilt University School of MedicineClass of 2004

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2022 - 2026
  • ME State Medical License
    ME State Medical License 2021 - 2026
  • RI State Medical License
    RI State Medical License 2021 - 2026
  • VT State Medical License
    VT State Medical License 2022 - 2026
  • CT State Medical License
    CT State Medical License 2021 - 2025
  • MA State Medical License
    MA State Medical License 2008 - 2025
  • NH State Medical License
    NH State Medical License 2021 - 2025
  • Dermatology
    American Board of Dermatology Dermatology

Awards, Honors, & Recognition

  • Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012

Publications & Presentations

PubMed

Lectures

  • Advanced Management of the Dermatologic Manifestations of Connective Tissue Diseases 
    American Academy of Dermatology - Annual Meeting 2019 - Washington, D.C. - 3/1/2019

Press Mentions

  • Novel Drug Eases Disease Activity in Dermatomyositis
    Novel Drug Eases Disease Activity in DermatomyositisJanuary 15th, 2025

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: